It has been reported that bone marrow stromal cells promote the acquisition of stem cell characteristics and resistance to chemotherapeutic agents in AML cells through the nonclassical TGF-β1/p38/ALDH2 signalling axis [14]. This evidence concerns the gene ALDH2 and acute myeloid leukemia.